Medtronic vs Thermo Fisher Scientific stock
Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.
Medtronic is cheaper for its profits. Thermo Fisher Scientific is more profitable, grows faster and has less debt.
Side by side
| Medtronic | Thermo Fisher Scientific | |
|---|---|---|
| $132 billion | $259 billion | |
| 13.2% | 15.0% | |
| +3.8% | +6.7% | |
| 27.4× | 38.7× | |
| 2.7 years | 2.6 years | |
| 7.2% | 7.6% | |
| 3.5% | 0.4% |
How we compare
Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.
More comparisons: Medtronic vs UnitedHealth · Medtronic vs AbbVie · Medtronic vs Amgen · Medtronic vs Bristol-Myers Squibb · Thermo Fisher Scientific vs Merck & · Thermo Fisher Scientific vs Regeneron Pharmaceuticals · Thermo Fisher Scientific vs Roche · Thermo Fisher Scientific vs Rockwell Automation

